LMNB1 and Alzheimer disease: In contrast, Lamin B1 immunostaining was always limited to the membrane both in healthy and AD conditions and only presented a slight increase at AD V-VI stages (Figure 5A–J), which did not reach statistical significance (Figure 5K–M).